Navigation Links
Neurognostics pushes early prediction of brain disease

Milwaukee Score one for early prediction: Neurognostics, a firm in Milwaukee that develops devices for magnetic resonance imaging (MRI), has made strides since its founding two years ago toward the treatment of disorders before any physical signs develop.

"MRI is the most popular and useful mapping technique in the world ... in research," said Steve Rao, founder and chief science ......

Full article >>> no to study their drug Aricept, using MRI to analyze how effective it was in treating patients with multiple sclerosis. Tucker said Neurognostics is in the middle of negotiations with two other firms for similar projects.

"We assist the pharmaceutical company in making go or no go solutions, and we can do this by showing it's more sensitive then paper-pencil tests," Rao said.

......

Full article >>> mpany is trying to find new sites that have limited experience with functional MRI so they can learn how it operates in a neutral environment.

"We're hitting the pavement finding implementation sites," Tucker said.

Tucker said the company also plans to build off a Phase I Small Business Innovation Research grant the company received in October from the National Institutes of Heal......

Full article >>>
'"/>

Source:wistechnology.com By Les Chappell 03/16/05


Related biology technology :

1. Neurognostics to partner with Racine distributor
2. Neurognostics partners with Medical Numerics
3. Neurognostics recognized for MRI award
4. Neurognostics receives special FDA clearance for MindState fDAD
5. Neurognostics receives award for MRI innovation
6. Silva-Craig joins Neurognostics board
7. Wisconsin pushes for adoption of electronic health records
8. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
9. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
10. Venture Investors early-stage fund grows to $115 million
11. GE acquisition may boost "early" healthcare strategy
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... AUSTIN, Texas , Feb. 11, 2016  Vermillion, ... focused on gynecologic disease, today announced the formation of ... --> --> Pelvic ... in both diagnosis and management. Once pregnancy is ruled ... fallopian tubes and ovaries, advanced endometriosis, benign ovarian tumors ...
(Date:2/11/2016)... , ... February 11, 2016 ... ... publication dedicated to delivering cutting-edge information focused on the development and manufacture ... to become a premier sponsor of the 2016 BioProcess International Awards – ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem Cells ... with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome injection and other ... including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, El Salvador, Venezuela, ...
(Date:2/10/2016)... Ky. , Feb. 10, 2016 NX ... utilizing its proprietary NeXosome® technology for early warning ... of its most recent study by Dr. ... at the Society for Maternal Fetal Medicine,s (SMFM) annual ... GA, February 1-6 th , 2016.  The presentation reported ...
Breaking Biology Technology:
(Date:2/9/2016)... Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... fourth quarter and year ended December 31, 2015.  ... of 2015 was $6.9 million, an increase of 61% compared to ... the fourth quarter of 2015 was $2.6 million compared to $0.2 ... --> --> Higher revenue and operating income in ...
(Date:2/4/2016)... The field of Human Microbiome research ... popular hubs of the biotechnology industry. While the ... of human microbiota, have garnered a lot of ... space has literally exploded in terms of both ... focuses on biomedical aspects of research, development, and ...
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
Breaking Biology News(10 mins):